Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	86.82	71.19	63.23	33.69	51.67	50.88
Short-Term Investments	176.05	284.54	431.01	297.5	148.93	226.01
Cash & Short-Term Investments	262.87	355.72	494.25	331.19	200.6	276.89
Cash Growth	-39.79%	-28.03%	49.23%	65.10%	-27.56%	169.42%
Accounts Receivable	-	-	-	1.98	2	9.28
Other Receivables	1.54	2.3	3	1.16	0.47	0.47
Receivables	1.54	2.3	3	3.14	2.47	9.75
Prepaid Expenses	1.28	2.98	4.53	4.85	5.4	3.36
Other Current Assets	1.76	1.26	3.73	1.13	0.98	0.76
Total Current Assets	267.44	362.26	505.5	340.31	209.44	290.75
Property, Plant & Equipment	30.51	32.77	4.78	9.91	10.94	4.32
Other Long-Term Assets	1.87	1.92	1.87	0.39	0.84	0.45
Total Assets	299.82	396.95	512.15	350.61	221.22	295.53
Accounts Payable	1.38	5.96	4.53	1.58	2.97	2.02
Accrued Expenses	17.98	26.72	22.68	19.88	11.99	9.49
Current Portion of Leases	1.23	0.54	1.32	2.46	1.87	-
Other Current Liabilities	-	-	-	-	-	0.09
Total Current Liabilities	20.59	33.22	28.52	23.91	16.83	11.6
Long-Term Debt	30.36	30.21	10.05	9.93	-	-
Long-Term Leases	28.79	29.44	-	3.43	5.33	-
Other Long-Term Liabilities	-	-	-	-	-	0.87
Total Liabilities	79.74	92.87	38.58	37.27	22.16	12.47
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,030	1,014	972.97	653.71	414.35	400.92
Retained Earnings	-809.52	-710.05	-499.75	-338.41	-215.09	-117.83
Comprehensive Income & Other	-0	0.32	0.35	-1.96	-0.2	-0.03
Total Common Equity	220.08	304.08	473.58	313.34	199.06	283.06
Shareholders' Equity	220.08	304.08	473.58	313.34	199.06	283.06
Total Liabilities & Equity	299.82	396.95	512.15	350.61	221.22	295.53
Total Debt	60.38	60.19	11.37	15.82	7.19	-
Net Cash (Debt)	202.5	295.53	482.87	315.37	193.4	276.89
Net Cash Growth	-46.20%	-38.80%	53.11%	63.07%	-30.15%	169.42%
Net Cash Per Share	3.32	4.88	8.22	7.51	5.40	12.97
Filing Date Shares Outstanding	61.39	61.24	60.24	58.94	36.11	35.74
Total Common Shares Outstanding	61.39	60.86	59.92	48.94	36.08	35.55
Working Capital	246.85	329.05	476.98	316.4	192.61	279.16
Book Value Per Share	3.59	5.00	7.90	6.40	5.52	7.96
Tangible Book Value	220.08	304.08	473.58	313.34	199.06	283.06
Tangible Book Value Per Share	3.59	5.00	7.90	6.40	5.52	7.96
Machinery	14.29	13.87	10.53	9.61	7.97	6.56
Construction In Progress	0.15	0.35	0.05	0.07	0.04	0.3
Leasehold Improvements	2.16	2.12	1.66	1.65	1.62	0.95

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q